Ophthalmic Handheld Surgical Instruments Market (2026 - 2033)

Ophthalmic Handheld Surgical Instruments Market Summary

The global ophthalmic handheld surgical instruments market size was valued at USD 2.1 billion in 2025 and is projected to grow from USD 2.3 billion in 2026 to USD 3.8 billion by 2033, at a CAGR of 7.2% from 2026 to 2033. North America dominated the market with the largest revenue share of approximately 35.0% in the global market in 2025. Factors expected to fuel growth in cutting-edge handheld surgical instruments during the projected period include the rising incidence of ocular conditions such as glaucoma, cataracts, and refractive errors; the increasing popularity of ambulatory surgery centers; patient preferences for shorter hospital stays; and the growing use of ophthalmic handheld surgical instruments.

The number of people with visual impairments and blindness is rising proportionally as the older population grows across the globe. Due to this, diseases such as cataracts, glaucoma, age-related macular degeneration, and diabetic retinopathy are increasing and are among the leading causes of vision loss and blindness. These factors have increased the need for surgeries, thereby driving demand for ophthalmic handheld surgical instruments.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

For instance, according to the American Academy of Ophthalmology, around 1.3 billion Americans aged 40 years and above have legal blindness, defined as visual acuity worse than or equal to 20/200 in the better-seeing eye after the best correction. For those with best-corrected visual acuity below 20/40 (including people who are legally blind), poor vision affects over 2.9 billion adults aged 40 and older.

Technological advancements and an increasing preference for minimally invasive surgical options that provide permanent solutions to common ophthalmic conditions are expected to boost the number of surgeries, especially in developing regions. In addition, the advent of minimally invasive surgical techniques, with potential advantages such as shorter recovery periods and shorter turnaround times in the treatment of glaucoma and cataracts, has increased the average number of ophthalmic surgeries performed worldwide.

Various government and non-government programs aimed at raising public awareness regarding visual impairments and providing financial assistance to patients for ophthalmic surgeries are anticipated to play a crucial role in the growth of the ophthalmic handheld surgical instrument industry. For instance, the government of India grants NGOs free ocular surgeries to perform on underprivileged patients living in remote areas under the National Programme for Control of Blindness (NPCB) scheme.

High levels of competition, outdated technologies, and a global shortage of ophthalmologists are among the factors expected to restrain growth in the ophthalmic-handled surgical tools market. Longer wait times due to a lack of ophthalmic surgeons lead some patients to forego ocular procedures in favor of other forms of treatment. The Association of American Medical Colleges (AAMC) projects a shortage of ophthalmologists by 2025.

Analyst Perspective

The global ophthalmic handheld surgical instruments industry is shifting from a niche health-food product to a leading segment within the premium functional spreads category. This growth is driven by rising consumer demand for plant-based, clean-label, and organic products, which are more nutrient-dense and protein-rich than traditional peanut butters. To capitalize on this trend, leading manufacturers are expanding their portfolios beyond traditional spreads to include organic options, new flavors, and products fortified with probiotics or plant proteins. However, the market faces significant risks due to supply challenges, particularly volatile raw almond prices driven by climate-related and water-sustainability concerns. Brands must secure climate-resilient, transparent supply chains, adopt eco-friendly packaging, and strengthen their omni-channel retail presence to balance premium positioning with affordability.

Product Insights

The ophthalmic knives segment led the market with the largest revenue share of over 70.0% in 2025, owing to the wide availability of ophthalmic knives in various shapes, sizes, and styles. Currently, two types of knives are used in eye surgeries - disposable and diamond knives. Diamond knives are experiencing a surge in demand owing to their advantages, including precision incisions, reusability, cost efficiency, and durability.

The scissors segment is expected to grow at the fastest CAGR over the forecast period. Scissors are the second most commonly found ophthalmic handheld instruments in the surgical kit of ocular procedures. They are widely classified by application as conjunctival, corneal, general ophthalmic, IOL, iris, stitch, tenotomy, Vannas, and strabismus scissors. Regular handheld surgical instrument kits for trabeculectomy and extracapsular cataract extraction typically include 3-6 types of scissors.

Ophthalmic handheld surgical instruments are made of materials such as titanium and stainless steel, which are readily available from local suppliers, thereby reducing the risk of market entry. It is estimated that 3-10 types of forceps are present in the surgical tray for ophthalmic surgeries, contributing to their significant revenue share. Moreover, key industry players are focusing on developing lightweight, durable, and corrosion-resistant forceps. For instance, MicroSurgical Technology developed the Gianetti MICS Capsulorhexis Forceps with very thin shanks and tips, enabling glaucoma surgeries to be performed more precisely.

End Use Insights

The hospital segment led the market with the largest revenue share of around 65.0%, in 2025. Procurement of ophthalmic handheld surgical instruments is generally a one-time activity due to their long shelf life. An increasing number of mobile ophthalmic care centers is expected to contribute significantly to the segment’s growth. For instance, the African Eye Foundation has invested USD 16 billion to construct a high-quality eye care facility that provides comprehensive ophthalmic surgical services to people in Cameroon in Central Africa.

The U.S. government covers the cost of cataract surgery for patients aged 65 and older. Medicare covers 80% of the total cost of cataract surgery, including pre- and post-operative examinations, cataract removal, intraocular lens implantation, and protective eyewear after the operation. Thus, hospitals continue to witness high admission rates.

The ophthalmic clinics segment is estimated to grow at the fastest CAGR over the forecast period. Ophthalmic clinics held the second-largest share in 2025 and are expected to witness the fastest growth over the forecast period. Factors such as the introduction of cutting-edge, cost-effective surgical devices and long hospital wait times are expected to drive segment growth during the forecast period. Ophthalmic clinics also eliminate unnecessary procedures or diagnostic tests, provided they do not affect the quality of clinical care. They provide better inpatient, outpatient, and emergency services for a wide range of eye conditions, thereby increasing patients' preference for ophthalmic clinics.

The others segment includes research centers, academics, and mobile ophthalmic units. The segment is expected to expand at a healthy CAGR over the projected period. Initiatives such as public awareness programs to dispel myths and reduce patients' fear of ocular surgeries, along with numerous public outreach programs, are anticipated to drive growth in this segment. For instance, the CBM Peru program provides cataract surgery services to people living in remote regions of Africa through mobile outreach camps.

Regional Insights

North America dominated the global ophthalmic handheld surgical instrument market with the largest revenue share of around 35.0% in 2025. Factors such as the high prevalence of ocular disorders, the presence of key players, and efficient reimbursement policies have contributed to its strong revenue share. For instance, healthcare payers such as Medicare and Medicaid consider cataract surgery a medically necessary service and cover it at no cost.

To learn more about this report, Download Free Sample Report

Asia Pacific Ophthalmic Handheld Surgical Instruments Market Trends

The ophthalmic handheld surgical instrument market in the Asia Pacific is expected to grow at the fastest CAGR during the forecast period. The significant gap between demand and supply of eye surgery services in countries such as India, China, Japan, and other Southeast Asian nations is expected to drive market growth. Significant unmet needs are driving service providers to plan and develop new eye care facilities in these regions. For instance, as per the International Agency for the Prevention of Blindness, in Asia, around 17 billion people have glaucoma, which is expected to rise to 30 billion by 2040. 

Key Ophthalmic Handheld Surgical Instruments Company Insights

Key players that dominated the global market include Haag-Streit Group, Appasamy Associates. These companies are collaborating with healthcare centers to provide a long-term supply of ophthalmic surgical instruments. Major market players are pursuing various strategies, including mergers and acquisitions, product launches, partnerships, and joint ventures.

Key Ophthalmic Handheld Surgical Instruments Companies

The following key companies have been profiled for this study on the ophthalmic handheld surgical instruments market.

• Haag-Streit Group

• Appasamy Associates

• Millennium Surgical Corporation

• Katalyst Surgical

• ASICO, LLC

• INKA Surgical Instruments

• Surgical Holdings 

Recent Developments

• In May 2025, Alcon launched the UNITY VCS Surgical System for ophthalmic procedures. The system incorporates advanced fluidics, connectivity, and workflow-optimization technologies to enhance surgical efficiency and precision during ophthalmic procedures, reflecting ongoing innovation in ophthalmic surgical equipment.

• In March 2025, BVI Medical announced the completion of a USD 1 billion partnership with TPG. The transaction, which included debt refinancing and new capital investment, strengthened the company’s financial position and supported initiatives in product development and global expansion, underscoring continued investment in the ophthalmic devices market.

Global Ophthalmic Handheld Surgical Instruments Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global ophthalmic handheld surgical instruments market report based on product, End Use, and region:

To learn more about this report, Download Free Sample Report

• Product Outlook (Revenue, USD Billion, 2021 - 2033)

  • Forceps

  • Scissor

  • Chopper

  • Ophthalmic Knives

  • Cannula

  • Others

• End Use Outlook (Revenue, USD Billion, 2021 - 2033)

  • Hospitals

  • Ophthalmic Clinics

  • Others

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Sweden

    • Norway

    • Denmark

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa

    • Saudi Arabia

    • South Africa

    • UAE

    • Kuwait